Patents by Inventor Alexander Redvers Eberlin

Alexander Redvers Eberlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
    Patent number: 9481667
    Abstract: Solid forms of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, solid forms thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: November 1, 2016
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Daniel G. Genov, Louis Grenier, Andrew B. Hague, Alexander Redvers Eberlin, Ludovic Sylvain Marc Renou, Susana Del Rio Gancedo
  • SALTS AND SOLID FORMS OF ISOQUINOLINONES AND COMPOSITION COMPRISING AND METHODS OF USING THE SAME
    Publication number: 20160024051
    Abstract: Solid forms of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, solid forms thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Daniel G. GENOV, Louis GRENIER, Andrew B. HAGUE, Alexander Redvers EBERLIN, Ludovic Sylvain Marc RENOU, Susana DEL RIO GANCEDO
  • Salts and solvates of a tetrahydroisoquinoline derivative
    Patent number: 9162985
    Abstract: (S)-2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid in substantially pure form is described together with its sodium salt and solvates. Methods for preparing the compound, its sodium salt and its solvates and pharmaceutical compositions comprising them are also described.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: October 20, 2015
    Assignee: Spinifex Pharmaceuticals Pty Ltd
    Inventors: Thomas David McCarthy, Craig James Stewart Boyle, Alexander Redvers Eberlin, Peter Michael Kelly
  • SALTS AND SOLVATES OF A TETRAHYDROISOQUINOLINE DERIVATIVE
    Publication number: 20150105422
    Abstract: (S)-2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid in substantially pure form is described together with its sodium salt and solvates. Methods for preparing the compound, its sodium salt and its solvates and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: December 17, 2014
    Publication date: April 16, 2015
    Applicant: SPINIFEX PHARMACEUTICALS PTY LTD
    Inventors: Thomas David McCarthy, Craig James Stewart Boyle, Alexander Redvers Eberlin, Peter Michael Kelly
  • Salts and solvates of a tetrahydroisoquinoline derivative
    Patent number: 8927575
    Abstract: (S)-2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid in substantially pure form is described together with its sodium salt and solvates. Methods for preparing the compound, its sodium salt and its solvates and pharmaceutical compositions comprising them are also described.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: January 6, 2015
    Assignee: Spinifex Pharmaceuticals Pty Ltd
    Inventors: Thomas David McCarthy, Craig James Stewart Boyle, Alexander Redvers Eberlin, Peter Michael Kelly
  • SALTS AND SOLID FORMS OF ISOQUINOLINONES AND COMPOSITION COMPRISING AND METHODS OF USING THE SAME
    Publication number: 20140275135
    Abstract: Solid forms of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, solid forms thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: Infinity Pharmaceuticals, Inc.
    Inventors: Daniel G. GENOV, Louis GRENIER, Andrew B. HAGUE, Alexander Redvers EBERLIN, Ludovic Sylvain Marc RENOU, Susana DEL RIO GANCEDO
  • SALTS AND SOLVATES OF A TETRAHYDROISOQUINOLINE DERIVATIVE
    Publication number: 20140080865
    Abstract: (S)-2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid in substantially pure form is described together with its sodium salt and solvates. Methods for preparing the compound, its sodium salt and its solvates and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 20, 2014
    Applicant: SPINIFEX PHARMACEUTICALS PTY LTD
    Inventors: Thomas David McCarthy, Craig James Stewart Boyle, Alexander Redvers Eberlin, Peter Michael Kelly
  • Salt and solvates of a tetrahydroisoquinoline derivative
    Patent number: 8614227
    Abstract: (S)-2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid in substantially pure form is described together with its sodium salt and solvates. Methods for preparing the compound, its sodium salt and its solvates and pharmaceutical compositions comprising them are also described.
    Type: Grant
    Filed: July 21, 2011
    Date of Patent: December 24, 2013
    Assignee: Spinifex Pharmaceuticals Pty Ltd
    Inventors: Thomas David McCarthy, Craig James Stewart Boyle, Alexander Redvers Eberlin, Peter Michael Kelly
  • SALT AND SOLVATES OF A TETRAHYDROISOQUINOLINE DERIVATIVE
    Publication number: 20120022101
    Abstract: (S)-2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid in substantially pure form is described together with its sodium salt and solvates. Methods for preparing the compound, its sodium salt and its solvates and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: July 21, 2011
    Publication date: January 26, 2012
    Applicant: SPINIFEX PHARMACEUTICALS PTY LTD,
    Inventors: Thomas David McCarthy, Craig James Stewart Boyle, Alexander Redvers Eberlin, Peter Michael Kelly
  • Motilide polymorphs
    Patent number: 8030282
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: October 4, 2011
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston
  • Motilide polymorphs
    Patent number: 7872109
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: January 18, 2011
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston
  • MOTILIDE POLYMORPHS
    Publication number: 20100227829
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Application
    Filed: April 16, 2010
    Publication date: September 9, 2010
    Applicant: PFIZER INC.
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston
  • 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
    Patent number: 7648976
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: January 19, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Peter J. Licari, Timothy Leaf, Ruchir P. Desai, Jorge L. Galazzo, Greg O. Buchanan, Stephen William Watt, Alexander Redvers Eberlin, Robert Arslanian
  • 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN POLYMORPHS AND FORMULATIONS
    Publication number: 20090042847
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxy-geldanamycin (17-AAG).
    Type: Application
    Filed: May 29, 2008
    Publication date: February 12, 2009
    Applicant: Kosan Biosciences Incorporated
    Inventors: Peter J. Licari, Timothy Leaf, Ruchir P. Desai, Jorge L. Galazzo, Greg O. Buchanan, Stephen William Watt, Alexander Redvers Eberlin, Robert Arslanian
  • Motilide polymorphs
    Publication number: 20080146654
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Application
    Filed: December 4, 2007
    Publication date: June 19, 2008
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston